Newsroom | 1387 results

Sorted by: Latest

COVID-19
-

Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced new and updated data from three arms of the ongoing Phase 1b/2 EPCORE® CLL-1 trial (NCT04623541) evaluating the efficacy and safety of epcoritamab-bysp, a T-cell engaging bispecific antibody administered subcutaneously, as a monotherapy and in combination for the treatment of patients with Richter transformation (RT), a rare complication in which chronic lymphocytic leukemia (CLL) evolves into an aggressive lymphoma...
-

AHF: Expresidentes y expertos llaman a Latinoamérica a actuar como bloque ante emergencias sanitarias

CIUDAD DE MÉXICO--(BUSINESS WIRE)--Sin cooperación regional, Latinoamérica no podrá enfrentar adecuadamente la próxima emergencia sanitaria. Este fue el mensaje central del panel de alto nivel organizado por el Instituto AHF de Salud Pública Global y el Laboratorio de Políticas Públicas en Salud de la Universidad de Miami, en el que líderes de la región coincidieron en que es urgente construir una arquitectura latinoamericana capaz de responder como bloque ante futuras crisis sanitarias. El web...
-

AHF: Former Presidents and Experts Call on Latin America to Act as a Bloc in the Face of Health Emergencies

MEXICO CITY--(BUSINESS WIRE)--Without regional cooperation, Latin America will not be able to adequately confront the next health emergency. This was the central message of the high-level panel organized by the AHF Global Public Health Institute and the University of Miami’s Public Health Policy Lab, where regional leaders agreed that it is urgent to build a Latin American architecture capable of responding as a bloc to future health crises. The webinar, moderated by Dr. Jorge Saavedra, Executi...
-

Arcturus Therapeutics to Attend Upcoming Investor Conference

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced that the Company will participate in the following investor conference: Piper Sandler 37th Annual Healthcare Conference (Fireside Chat) Tuesday, December 2, 2025 (12:30 p.m. ET) About Arcturus Founded in 2013 and based i...
-

mRNA Vaccines Market Forecast 2025-2032 | Industry to Double in Size | Regulatory Fast Track Approvals and Adaptive Licensing Frameworks Accelerating Next Generation mRNA Vaccines - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "mRNA Vaccines Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The mRNA Vaccines Market is experiencing significant growth, evolving from USD 9.32 billion in 2024 to an anticipated USD 23.38 billion by 2032 with a robust CAGR of 12.17%. This market research report offers a comprehensive analysis on the progression of mRNA vaccine technologies, influencing strategic planning, competitive advantages, and identifying key opportu...
-

COVID-19 Diagnostic Research Report 2025: 5 Year Forecast by Technology, Product, Channel and Country, with Executive and Consultant Guides - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global COVID-19 Diagnostic Market: Forecast by Technology, Product, Channel and Country, with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering. The COVID-19 pandemic's impact lingers, transforming the landscape of respiratory diagnostics. While the immediate crisis has subsided, the virus remains, heralding a fiercely competitive industry eager to capitalize on a lucrative future. This new era sees testing progressively integrate...
-

Global Healthy Living Foundation Launches New Vaccine Hub to Strengthen National Advocacy and Protect Immunocompromised Americans

UPPER NYACK, N.Y.--(BUSINESS WIRE)--GHLF Website/Hub provides U.S. patients with centralized vaccine information repository...
-

Andor Health's ThinkAI Spotlights Agentic AI Solution to U.S. Hospital System Collapse

ORLANDO, Fla.--(BUSINESS WIRE)--Andor Health: WHAT: The U.S. hospital system faces total collapse from post-COVID fallout: over 100,000 nurses have quit since 2020, with 610,000 more planning to exit by 2027. Compounded by the opioid epidemic, migration to under-resourced rural areas, and rising tech-induced mental health disorders, emergency departments report 92% overload, straining overall capacity and fragmenting care. ThinkAndor®, Andor Health's Microsoft Teams-integrated platform, emerges...
-

Andor Health's ThinkAI Spotlights Agentic AI Solution to U.S. Hospital System Collapse

ORLANDO, Fla.--(BUSINESS WIRE)--Andor Health: WHAT: The U.S. hospital system faces total collapse from post-COVID fallout: over 100,000 nurses have quit since 2020, with 610,000 more planning to exit by 2027. Compounded by the opioid epidemic, migration to under-resourced rural areas, and rising tech-induced mental health disorders, emergency departments report 92% overload, straining overall capacity and fragmenting care. ThinkAndor®, Andor Health's Microsoft Teams-integrated platform, emerges...
-

Global Healthy Living Foundation Launches GetMyCOVIDVax

UPPER NYACK, N.Y.--(BUSINESS WIRE)--Patients and physicians can find convenient vaccination pharmacy locations with new GHLF tool...